Back to Search
LUCA PAOLUZZI, M.D.
M.D.
Medical Oncology Physician
NPI: 1821232018Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
280371(NY)
Research & Publications (10)
The anti-histaminic cyproheptadine synergizes the antineoplastic activity of bortezomib in mantle cell lymphoma through its effects as a histone deacetylase inhibitor.
PMID 19604235·Br J Haematol·2009
7-preclinical
Targeting Bcl-2 family members with the BH3 mimetic AT-101 markedly enhances the therapeutic effects of chemotherapeutic agents in in vitro and in vivo models of B-cell lymphoma.
PMID 18292288·Blood·2008
7-preclinical
The BH3-only mimetic ABT-737 synergizes the antineoplastic activity of proteasome inhibitors in lymphoid malignancies.
PMID 18591385·Blood·2008
7-preclinical
Mechanistic rationale and clinical evidence for the efficacy of proteasome inhibitors against indolent and mantle cell lymphomas.
PMID 16573348·BioDrugs·2006
6-review
Influence of genetic variants in UGT1A1 and UGT1A9 on the in vivo glucuronidation of SN-38.
PMID 15286088·J Clin Pharmacol·2004
8-other
Histone deacetylase inhibitors are potent radiation protectants.
PMID 15136769·Cancer Biol Ther·2004
6-review
Weekly gemcitabine, paclitaxel, oxaliplatin combination chemotherapy in patients with Cisplatin-refractory germ cell tumor: preliminary experience.
PMID 15596910·Am J Clin Oncol·2004
3-trial
Phase I/II trial of gemcitabine plus cisplatin and etoposide in patients with small-cell lung cancer.
PMID 12609572·Lung Cancer·2003
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 111 E 210TH ST
BRONX, NY 10467 - Phone
- (189) 204-8267
Quick Facts
- NPI
- 1821232018
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 10
Are you this provider?
Claim Your Profile